Arnason, Jon
Beth Israel Deaconess Medical Center
3 papers on CoChatORCID 0000-0001-9038-7277
Most cited papers
- Verified
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Abramson, J. S., Palomba, M. L., Gordon, L. I., Lunning, M. A., Wang, M., Arnason, J., Mehta, A., Purev, E., Maloney, D. G., Andreadis, C., et al. (2020) · The Lancet
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 2,430
- Verified
Lenalidomide enhances anti-myeloma cellular immunity
Luptakova, K., Rosenblatt, J., Glotzbecker, B., Mills, H., Stroopinsky, D., Kufe, T., Vasir, B., Arnason, J., Tzachanis, D., Zwicker, J. I., et al. (2013) · Cancer Immunology, Immunotherapy
Multiple Myeloma Research and TreatmentsImmunotherapy and Immune Responses
Cited by 162
- Verified
Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational use
Warner, J. L., & Arnason, J. E. (2012) · Therapeutic Advances in Hematology
Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment
Cited by 31
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free